Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons

4 Nov 2020

Abstract excerpt

While an appropriately regulated production of interferons (IFNs) performs a fundamental role in the defense against coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), dysregulated overproduction of inflammatory mediators can play an important role in the development of SARS-CoV-2 infection-related complications, such as acute respiratory distress syndrome. As the principal...

Topics

Join the communities discussing this publication.

COVID-19 Clinical Research Studies
Long-Term Effects of COVID-19
SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33147113
DOI: 10.1089/vim.2020.0076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III InterferonsPMID 33147113Read ↗

Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patientsSemantic proximity Read ↗

Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.Semantic proximity Read ↗

Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infectionSemantic proximity Read ↗

Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN FunctionsSemantic proximity Read ↗

Type I interferons and SARS-CoV-2: from cells to organismsSemantic proximity Read ↗

The interferon landscape along the respiratory tract impacts the severity of COVID-19Semantic proximity Read ↗

[Review] The Landscape of Interferons in Health and DiseaseSemantic proximity Read ↗

Type I IFN family members: similarity, differences and interaction.Semantic proximity Read ↗

Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19Semantic proximity Read ↗

Human type-I interferon omega holds potent antiviral properties and promotes cytolytic CD8 <sup>+</sup> T cell responsesSemantic proximity Read ↗

Interferon antagonists encoded by SARS-CoV-2 at a glanceSemantic proximity Read ↗

SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.